Paragon Genomics Introduces CleanPlex® UMI Panel for Ultrafast, Precise Analysis of Lung Cancer Hotspot Mutations at ASHG 2018
Retrieved on:
Thursday, October 11, 2018
HAYWARD, Calif., Oct. 11, 2018 /PRNewswire/ --Paragon Genomics, Inc. today announced the introduction of its CleanPlex UMI Lung Cancer Panel at the upcoming 2018 Annual Meeting of the American Society of Hunan Genetics (ASHG).
Key Points:
- HAYWARD, Calif., Oct. 11, 2018 /PRNewswire/ --Paragon Genomics, Inc. today announced the introduction of its CleanPlex UMI Lung Cancer Panel at the upcoming 2018 Annual Meeting of the American Society of Hunan Genetics (ASHG).
- The new CleanPlex UMI Lung Cancer Panel is a targeted resequencing assay designed for rapid and high confidence detection of ultralow-frequency variants across the hotspot regions of 23 genes frequently associated with lung cancer.
- The Lung Cancer Panel is our first using the CleanPlex UMI technology.
- Paragon Genomics researchers are presenting a poster 1 at ASHG that discusses and characterizes the performance of the CleanPlex UMI technology.